Showing results (121-130 of 260) with videos related to
Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|February 3, 2016
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?Piergiorgio Cojutti, Silvia Duranti, Miriam Isola, et al.Basic & Clinical Pharmacology & Toxicology|April 8, 2014
Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoringFederico Pea, Lucia Dose, Piergiorgio Cojutti, et al.The Journal of Antimicrobial Chemotherapy|August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipientsMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.Journal of Anesthesia, Analgesia and Critical Care|December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infectionsMilo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.The Annals of Pharmacotherapy|July 14, 2011
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patientFederico Pea, Piergiorgio Cojutti, Rodolfo Sbrojavacca, et al.Antimicrobial Agents and Chemotherapy|July 29, 2005
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposureFederico Pea, Pierluigi Viale, Daniela Damiani, et al.Pharmacological Research|November 10, 2006
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral doseFederico Pea, Gino Marioni, Federica Pavan, et al.Antimicrobial Agents and Chemotherapy|February 27, 2024
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing EnterobacteralesPier Giorgio Cojutti, Manjunath P Pai, Tommaso Tonetti, et al.International Journal of Antimicrobial Agents|May 16, 2023
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.International Journal of Antimicrobial Agents|February 22, 2023
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infectionsMilo Gatti, Vincent H Tam, Paolo Gaibani, et al.Pageof 26